Alternative Medicine Biomolecules in the Management of Gastrointestinal Tract Infections
Year: 2026
Type: article
Abstract: Gastrointestinal tract (GIT) infections range from self-limiting diarrhoeal illnesses to serious diseases associated with dehydration, intestinal injury, systemic complications, or outbreaks. The supplied review article highlights antimicrobial resistance among enteric pathogens and the limitations of indiscriminate antibiotic exposure, including disruption of the normal intestinal microbiota. Against this background, plant-derived biomolecules and traditional formulations have attracted research interest as possible antimicrobial or supportive agents. This project reviews four principal examples discussed in the source article: berberine, an isoquinoline alkaloid associated with Berberis aristata and Coptis chinensis; allicin, an organosulfur compound formed when garlic tissue is disrupted; curcumin, a polyphenol from Curcuma longa; and Triphala, a traditional formulation containing Phyllanthus emblica, Terminalia chebula, and Terminalia bellirica. Proposed mechanisms include effects on bacterial membranes, efflux pumps, virulence and biofilm pathways, inflammatory signalling, and mucosal protection. The report also considers key translational limitations: variable phytochemical content, poor aqueous solubility or bioavailability for some compounds, possible interactions, and a shortage of consistent clinical standardization. Nanocarriers such as liposomes, solid lipid nanoparticles, and polymeric nanoparticles are discussed as research strategies that may improve delivery. The evidence described in the supplied article is promising but should not be interpreted as proof that these agents can replace established treatment. Further standardized preclinical and clinical studies are needed.
Language: English
Subfield: Food Science
Domain: Life Sciences
Keywords: gastrointestinal infections, plant-derived antimicrobials, berberine, allicin, curcumin, Triphala, antimicrobial resistance, enteric pathogens, gut microbiota disruption, biofilm inhibition, efflux pumps, mucosal protection, nanocarriers, liposomes, solid lipid nanoparticles, polymeric nanoparticles, bioavailability, traditional formulations
Open Access status: green
OpenAlex ID: W7234304972
